A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of Lumbar Total Disc Replacement With the CHARITÉ ™ Artificial Disc Versus Lumbar Fusion

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITÉ artificial disc versus lumbar fusion: Five-year follow-up

The Spine Journal ◽

10.1016/j.spinee.2008.08.007 ◽

2009 ◽

Vol 9 (5) ◽

pp. 374-386 ◽

Cited By ~ 196

Author(s):

Richard D. Guyer ◽

Paul C. McAfee ◽

Robert J. Banco ◽

Fabian D. Bitan ◽

Andrew Cappuccino ◽

...

Keyword(s):

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artifiical Disc Versus Lumbar Fusion: Part II: Evaluation of Radiographic Outcomes and Correlation of Surgical Technique Accuracy With Clinical Outcomes

Yearbook of Orthopedics ◽

10.1016/s0276-1092(08)70536-4 ◽

2006 ◽

Vol 2006 ◽

pp. 260-261 ◽

Author(s):

M.J. Yaszemski

Keyword(s):

Surgical Technique ◽

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Radiographic Outcomes ◽

Faculty Opinions recommendation of A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9142.466622 ◽

2006 ◽

Author(s):

Constantin Schizas

Keyword(s):

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemptions Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artificial Disc Versus Lumbar Fusion: Part 1: Evaluation of Clinical Outcomes

Yearbook of Orthopedics ◽

10.1016/s0276-1092(08)70535-2 ◽

2006 ◽

Vol 2006 ◽

pp. 258-259

Author(s):

M.J. Yaszemski

Keyword(s):

Clinical Outcomes ◽

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemptions Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artificial Disc Versus Lumbar Fusion

Spine ◽

10.1097/01.brs.0000170587.32676.0e ◽

2005 ◽

Vol 30 (14) ◽

pp. 1565-1575 ◽

Cited By ~ 387

Author(s):

Scott Blumenthal ◽

Paul C. McAfee ◽

Richard D. Guyer ◽

Stephen H. Hochschuler ◽

Fred H. Geisler ◽

...

Keyword(s):

Drug Administration ◽

Lumbar Fusion ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

Re: “Prospective, randomized multicenter Food and Drug Administration investigational device exemption study of lumbar tool disc replacement with the CHARITÉ artificial disc versus lumbar fusion: five-year follow-up”

The Spine Journal ◽

10.1016/j.spinee.2009.10.009 ◽

2010 ◽

Vol 10 (4) ◽

pp. 360 ◽

Author(s):

Richard D. Guyer

Keyword(s):

Drug Administration ◽

Lumbar Fusion ◽

Disc Replacement ◽

Artificial Disc ◽

The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment

SAS Journal ◽

10.1016/s1935-9810(07)70041-5 ◽

2007 ◽

Vol 1 (1) ◽

pp. 8-11 ◽

Cited By ~ 2

Author(s):

Scott L. Blumenthal ◽

Richard D. Guyer ◽

Fred H. Geisler ◽

Paul C. McAfee ◽

John J. Regan

Keyword(s):

United States ◽

Adverse Events ◽

Drug Administration ◽

Total Disc Replacement ◽

The United States ◽

Disc Replacement ◽

54 Total disc replacement (TDR)lumbarFood and Drug Administration-Investigational Device Exemption (FDA-IDE) trialsTotal disc replacement (TDR)lumbarcomplications ofLumbar spinetotal disc replacement (TDR)Food and Drug Administration-Investigational Device Exemption (FDA-IDE) trialsLumbar spinetotal disc replacement (TDR)complications ofComplicationsof lumbar total disc replacement (TDR)Arthroplasty, disclumbarFood and Drug Administration-Investigational Device Exemption (FDA-IDE) trialsArthroplasty, disclumbarcomplications ofComplications of Investigational Device Exemption Trial after Total Disc Replacement

Dynamic Reconstruction of the Spine ◽

10.1055/b-0035-108566 ◽

2015 ◽

Keyword(s):

Drug Administration ◽

Total Disc Replacement ◽

Disc Replacement ◽

9:31113. Lumbar Total Disc Replacement With the ProDisc-L Artificial Disc versus Fusion: A Prospective Randomized Multi-Center Food and Drug Administration IDE Trial

The Spine Journal ◽

10.1016/j.spinee.2006.06.142 ◽

2006 ◽

Vol 6 (5) ◽

pp. 55S-56S ◽

Author(s):

Rick B. Delamarter ◽

Jack Zigler ◽

Jeffrey Spivak ◽

Raymond Linovitz ◽

Guy Danielson ◽

...

Keyword(s):

Drug Administration ◽

Total Disc Replacement ◽

Disc Replacement ◽

Artificial Disc ◽

The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment

The International Journal of Spine Surgery ◽

10.1016/sasj-2006-0001-rr ◽

2007 ◽

Vol 1 (1) ◽

pp. 8-11

Author(s):

Scott L. Blumenthal ◽

Richard D. Guyer ◽

Fred H. Geisler ◽

Paul C. McAfee ◽

John J. Regan

Keyword(s):

United States ◽

Adverse Events ◽

Drug Administration ◽

Total Disc Replacement ◽

The United States ◽

Disc Replacement ◽